School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, 230032, China.
School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, 230032, China.
Biomed Pharmacother. 2021 Feb;134:111099. doi: 10.1016/j.biopha.2020.111099. Epub 2020 Dec 15.
Colorectal cancer (CRC) is known as the third most common cancer as well as the fourth most deadly cancer worldwide. CRC accounts for approximately 10 % of all new cancer cases globally, remaining the second most frequent cause of cancer-related deaths. MicroRNAs (miRNAs) are a class of small noncoding RNAs that can affect a variety of cellular and molecular targets. Depending on the cell environment in which the information is expressed, miRNAs can serve as a CRC suppressor or promoter and play essential roles in several biological processes. In this review, we summarized the relationship between miRNAs and proliferation, metastasis, angiogenesis, autophagy, apoptosis, and the chemoradiotherapy of CRC, revealing that relevant miRNAs could serve as potential targets for CRC therapy.
结直肠癌(CRC)是世界上第三大常见癌症,也是第四大最致命的癌症。CRC 约占全球所有新发癌症病例的 10%,仍是癌症相关死亡的第二大常见原因。微小 RNA(miRNA)是一类小的非编码 RNA,可以影响多种细胞和分子靶标。根据表达信息的细胞环境,miRNA 可以作为 CRC 的抑制剂或促进剂,并在几个生物学过程中发挥重要作用。在这篇综述中,我们总结了 miRNA 与 CRC 的增殖、转移、血管生成、自噬、凋亡和放化疗之间的关系,表明相关 miRNA 可以作为 CRC 治疗的潜在靶点。